Please assess the completion status of the following clinical trial:

Trial Title: Fibrin Sealant in Preventing Fluid Build Up During Surgery in Patients Undergoing Breast Reconstruction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who will be undergoing latissimus dorsi donor flap harvest reconstruction and evaluated by the Department of Plastic and Reconstructive Surgery at Oregon Health and Science University (OHSU)~* These patients will be undergoing reconstructive surgery for a mastectomy/wide local excision of breast cancer defect or other soft tissue defect resulting from trauma, infection, undesirable surgical outcome, oncologic resection, etc.~* Ability to understand and the willingness to sign a written informed consent document~Exclusion Criteria:~* Patients who will not qualify for latissimus dorsi donor flap reconstruction based on anatomical limitations specific the subjects respectively; to be evaluated by the plastic surgeon~* History of allergic reactions attributed to compounds of similar chemical or biologic composition to fibrin glue sealant~* Patients with evidence of hematological disorders resulting in deficient coagulation whereby sharp dissection would result in undesirable bleeding otherwise performed more safely with electrosurgery

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm I (fibrin sealant) (Type: EXPERIMENTAL): Patients undergo sharp dissection technique with fibrin sealant closure.
- Arm II (standard electrocoagulation) (Type: ACTIVE_COMPARATOR): Patients undergo standard electrocoagulation dissection technique.

Based on this trial design, predict the completion outcome and termination type (if applicable).